Kane Biotech Inc. (KNBIF)

USD 0.05

(0.0%)

Gross Profit Summary of Kane Biotech Inc.

  • Kane Biotech Inc.'s latest annual gross profit in 2023 was 109.47 Thousand CAD , down -92.25% from previous year.
  • Kane Biotech Inc.'s latest quarterly gross profit in 2024 Q2 was 360.49 Thousand CAD , up 2663.62% from previous quarter.
  • Kane Biotech Inc. reported a annual gross profit of 1.41 Million CAD in annual gross profit 2022, up 148.61% from previous year.
  • Kane Biotech Inc. reported a annual gross profit of 568.44 Thousand CAD in annual gross profit 2021, up 7.89% from previous year.
  • Kane Biotech Inc. reported a quarterly gross profit of 360.49 Thousand CAD for 2024 Q2, up 2663.62% from previous quarter.
  • Kane Biotech Inc. reported a quarterly gross profit of -129.12 Thousand CAD for 2023 FY, down -109.14% from previous quarter.

Annual Gross Profit Chart of Kane Biotech Inc. (2023 - 2003)

Historical Annual Gross Profit of Kane Biotech Inc. (2023 - 2003)

Year Gross Profit Gross Profit Growth
2023 109.47 Thousand CAD -92.25%
2022 1.41 Million CAD 148.61%
2021 568.44 Thousand CAD 7.89%
2020 526.85 Thousand CAD -13.62%
2019 609.91 Thousand CAD 428.19%
2018 115.47 Thousand CAD -87.35%
2017 912.89 Thousand CAD 657.4%
2016 120.53 Thousand CAD 102.25%
2015 59.59 Thousand CAD 166.88%
2014 22.33 Thousand CAD -86.04%
2013 159.94 Thousand CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD -100.0%
2007 17.15 Thousand CAD -28.81%
2006 24.09 Thousand CAD 8.97%
2005 22.11 Thousand CAD 64.87%
2004 13.41 Thousand CAD -82.5%
2003 76.64 Thousand CAD 0.0%

Peer Gross Profit Comparison of Kane Biotech Inc.

Name Gross Profit Gross Profit Difference
Bioxytran, Inc. -8285.00 USD 1421.304%
Eiger BioPharmaceuticals, Inc. 14.99 Million USD 99.27%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 9.79 Million USD 98.882%
Intellipharmaceutics International Inc. 65.72 Thousand USD -66.55%
Evofem Biosciences, Inc. 11.7 Million USD 99.065%
Santhera Pharmaceuticals Holding AG 119.1 Million USD 99.908%
Propanc Biopharma, Inc. -34.15 Thousand USD 420.556%
Marizyme, Inc. 457.7 Thousand USD 76.083%
Genus plc 178.7 Million USD 99.939%
Pharming Group N.V. 220.1 Million USD 99.95%
Therapeutic Solutions International, Inc. 62.22 Thousand USD -75.923%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 73.311%
Nymox Pharmaceutical Corporation -11 Thousand USD 1095.182%
ContraFect Corporation -154 Thousand USD 171.084%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -42.611%
IMV Inc. -962.29 Thousand USD 111.376%
AXIM Biotechnologies, Inc. -387.5 Thousand USD 128.25%
ONE Bio Corp. 20.12 Million USD 99.456%
RVL Pharmaceuticals plc 40.26 Million USD 99.728%
Mesoblast Limited -35.16 Million USD 100.311%
MultiCell Technologies, Inc. 49.32 USD -221858.637%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 28.25 Million USD 99.613%
Genscript Biotech Corporation 409.55 Million USD 99.973%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated 3102.00 USD -3429.014%
Biomind Labs Inc. -15.42 Thousand USD 809.738%
Provectus Biopharmaceuticals, Inc. -1.14 Million USD 109.589%
Oncotelic Therapeutics, Inc. 70 Thousand USD -56.386%
Skye Bioscience, Inc. -124.25 Thousand USD 188.104%
GlobeStar Therapeutics Corporation - USD -Infinity%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
THC Farmaceuticals, Inc. -4952.00 USD 2310.622%
PsyBio Therapeutics Corp. -50 Thousand USD 318.94%
Arch Therapeutics, Inc. -2439.00 USD 4588.315%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 140.5 Thousand USD 22.085%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -123.865%
Q BioMed Inc. -8988.00 USD 1317.957%
GB Sciences, Inc. -624.00 USD 17643.269%
Alpha Cognition Inc. -86.02 Thousand USD 227.249%
CSL Limited 7.56 Billion USD 99.999%
Agentix Corp. - USD -Infinity%
American Oriental Bioengineering, Inc. 44.35 Million USD 99.753%
Enzolytics Inc. 30.7 Thousand USD -256.487%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 482.43 Thousand USD 77.309%
MetaStat, Inc. - USD -Infinity%
Curative Biotechnology, Inc. -97.51 Thousand USD 212.26%
argenx SE 1.1 Billion USD 99.99%
Northwest Biotherapeutics, Inc. -25.79 Million USD 100.424%
HST Global, Inc. - USD -Infinity%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation -208.00 USD 52729.808%
Endonovo Therapeutics, Inc. -514.51 Thousand USD 121.277%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Zenith Capital Corp. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. -8856.00 USD 1336.111%
AVAX Technologies, Inc. 617.38 Thousand USD 82.269%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. -83.84 Thousand USD 230.556%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Helix BioMedix, Inc. 987.98 Thousand USD 88.92%
Capstone Therapeutics Corp. 9.61 Million USD 98.861%
Kadimastem Ltd -630.13 Thousand USD 117.372%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
BioStem Technologies, Inc. 15.42 Million USD 99.29%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation -11.83 Thousand USD 1024.968%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated -48.25 Thousand USD 326.839%
Regen BioPharma, Inc. 176.56 Thousand USD 37.998%
Regen BioPharma, Inc. 176.56 Thousand USD 37.998%
Affymax, Inc. 1.35 Million USD 91.934%
Mobile Lads Corp. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
International Stem Cell Corporation 4.6 Million USD 97.624%
CytoDyn Inc. -29 Thousand USD 477.483%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 450.04 Thousand USD 75.676%
SYBLEU INC 11.69 Thousand USD -835.961%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. -319.5 Thousand USD 134.262%
Rebus Holdings, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. - USD -Infinity%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. -373 Thousand USD 129.349%
Neutra Corp. 14.33 Thousand USD -663.655%
Windtree Therapeutics, Inc. -82 Thousand USD 233.5%
PureTech Health plc -1.6 Million USD 106.829%
Coeptis Therapeutics, Inc. -1 Million USD 110.933%
IXICO plc 3.27 Million USD 96.652%
IntelGenx Technologies Corp. -694 Thousand USD 115.774%
Gelesis Holdings, Inc. -1.79 Million USD 106.112%
CSL Limited 7.7 Billion USD 99.999%
Cellectis S.A. 18 Thousand USD -508.167%